Ketamine exposure in adult mice leads to increased cell death in C3H, DBA2 and FVB inbred mouse strains

Drug and Alcohol Dependence

Volumn 92, Issue 1-3, 2008, Pages 217-227

  Majewski Tiedeken, Chalon R ^a   Rabin, Cara R ^a   Siegel, Steven J ^a  

^a UNIVERSITY OF PENNSYLVANIA   (United States)

Author keywords

Apoptosis; Drug effects; Ketamine; Neurotoxicity; NMDA receptor; Physiology

Indexed keywords

CASPASE 3; KETAMINE;

ANIMAL BEHAVIOR; APOPTOSIS; ARTICLE; COGNITIVE DEFECT; CONTROLLED STUDY; HIPPOCAMPUS; HISTOGRAM; MALE; MOUSE; MOUSE STRAIN; NONHUMAN; PRIORITY JOURNAL; STEREOMETRY;

ANIMALS; CASPASE 3; CELL DEATH; CELL NUCLEUS; EVOKED POTENTIALS; EXCITATORY AMINO ACID ANTAGONISTS; HIPPOCAMPUS; IMMUNOHISTOCHEMISTRY; KETAMINE; MALE; MICE; MICE, INBRED C3H; MICE, INBRED DBA; MICE, INBRED STRAINS; NERVE DEGENERATION; NEUROTOXICITY SYNDROMES; SILVER STAINING; SPECIES SPECIFICITY;

MUS;

EID: 36749043267     PISSN: 03768716     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.drugalcdep.2007.08.009     Document Type: Article

References (95)

1. Adams S.M., de Rivero Vaccari J.C., and Corriveau R.A. Pronounced cell death in the absence of NMDA receptors in the developing somatosensory thalamus. J. Neurosci. 24 (2004) 9441-9450
2. Berman R.M., Cappiello A., Anand A., Oren D.A., Heninger G.R., Charney D.S., and Krystal J.H. Antidepressant effects of ketamine in depressed patients. Biol. Psychiatr. 47 (2000) 351-354
3. Brisman J.L., Cosgrove G.R., Thornton A.F., Beer T., Bradley-Moore M., Shay C.T., Hedley-Whyte E.T., and Cole A.J. Hyperacute neuropathological findings after proton beam radiosurgery of the rat hippocampus. Neurosurgery 56 (2005) 1330-1337 discussion 1337-1338
4. Brosnan-Watters G., Ogimi T., Ford D., Tatekawa L., Gilliam D., Bilsky E.J., and Nash D. Differential effects of MK-801 on cerebrocortical neuronal injury in C57BL/6J, NSA, and ICR mice. Prog. Neuropsychopharm. Biol. Psychiatr. 24 (2000) 925-938
5. Collins M.A., Corso T.D., and Neafsey E.J. Neuronal degeneration in rat cerebrocortical and olfactory regions during subchronic "binge" intoxication with ethanol: possible explanation for olfactory deficits in alcoholics. Alcohol Clin. Exp. Res. 20 (1996) 284-292
6. Corso T.D., Sesma M.A., Tenkova T.I., Der T.C., Wozniak D.F., Farber N.B., and Olney J.W. Multifocal brain damage induced by phencyclidine is augmented by pilocarpine. Brain Res. 752 (1997) 1-14
7. Creeley C., Wozniak D.F., Labruyere J., Taylor G.T., and Olney J.W. Low doses of memantine disrupt memory in adult rats. J. Neurosci. 26 (2006) 3923-3932
8. Creeley C.E., Wozniak D.F., Nardi A., Farber N.B., and Olney J.W. Donepezil markedly potentiates memantine neurotoxicity in the adult rat brain. Neurobiol. Aging (2006)
9. Cruz-Orive L.M., and Weibel E.R. Sampling designs for stereology. J. Microsc. 122 (1981) 235-257
10. Curran H.V., and Monaghan L. In and out of the K-hole: a comparison of the acute and residual effects of ketamine in frequent and infrequent ketamine users. Addiction 96 (2001) 749-760
11. Curran H.V., and Morgan C. Cognitive, dissociative and psychotogenic effects of ketamine in recreational users on the night of drug use and 3 days later. Addiction 95 (2000) 575-590
12. Davies S.J., Field P.M., and Raisman G. Regeneration of cut adult axons fails even in the presence of continuous aligned glial pathways. Exp. Neurol. 142 (1996) 203-216
13. de Olmos J.S., Beltramino C.A., and de Olmos de Lorenzo S. Use of an amino-cupric-silver technique for the detection of early and semiacute neuronal degeneration caused by neurotoxicants, hypoxia, and physical trauma. Neurotoxicol. Teratol. 16 (1994) 545-561
14. de Rivero Vaccari J.C., Casey G.P., Aleem S., Park W.M., and Corriveau R.A. NMDA receptors promote survival in somatosensory relay nuclei by inhibiting Bax-dependent developmental cell death. Proc. Natl. Acad. Sci. U.S.A. 103 (2006) 16971-16976
15. DeOlmos J.S., and Ingram W.R. An improved cupric-silver method for impregnation of axonal and terminal degeneration. Brain Res. 33 (1971) 523-529
16. Dorph-Petersen K.A., Nyengaard J.R., and Gundersen H.J. Tissue shrinkage and unbiased stereological estimation of particle number and size. J. Microsc. 204 (2001) 232-246
17. Duncan E.J., Madonick S.H., Parwani A., Angrist B., Rajan R., Chakravorty S., Efferen T.R., Szilagyi S., Stephanides M., Chappell P.B., Gonzenbach S., Ko G.N., and Rotrosen J.P. Clinical and sensorimotor gating effects of ketamine in normals. Neuropsychopharmacology 25 (2001) 72-83
18. Duncan G.E., Miyamoto S., Leipzig J.N., and Lieberman J.A. Comparison of brain metabolic activity patterns induced by ketamine, MK-801 and amphetamine in rats: support for NMDA receptor involvement in responses to subanesthetic dose of ketamine. Brain Res. 843 (1999) 171-183
19. Farber N.B. The NMDA receptor hypofunction model of psychosis. Ann. N.Y. Acad. Sci. 1003 (2003) 119-130
20. Farber N.B., Heinkel C., Dribben W.H., Nemmers B., and Jiang X. In the adult CNS, ethanol prevents rather than produces NMDA antagonist-induced neurotoxicity. Brain Res. 1028 (2004) 66-74
21. Farber N.B., and Olney J.W. Drugs of abuse that cause developing neurons to commit suicide. Brain Res. Dev. Brain Res. 147 (2003) 37-45
22. Farber N.B., Wozniak D.F., Price M.T., Labruyere J., Huss J., St Peter H., and Olney J.W. Age-specific neurotoxicity in the rat associated with NMDA receptor blockade: potential relevance to schizophrenia?. Biol. Psychiatr. 38 (1995) 788-796
23. Fidecka S. Opioid mechanisms of some behavioral effects of ketamine. Pol. J. Pharmacol. Pharm. 39 (1987) 353-360
24. Flores G., Alquicer G., Silva-Gomez A.B., Zaldivar G., Stewart J., Quirion R., and Srivastava L.K. Alterations in dendritic morphology of prefrontal cortical and nucleus accumbens neurons in post-pubertal rats after neonatal excitotoxic lesions of the ventral hippocampus. Neuroscience 133 (2005) 463-470
25. Gallyas F., Farkas O., and Mazlo M. Traumatic compaction of the axonal cytoskeleton induces argyrophilia: histological and theoretical importance. Acta. Neuropathol. (Berl.) 103 (2002) 36-42
26. Gardella D., Hatton W.J., Rind H.B., Rosen G.D., and von Bartheld C.S. Differential tissue shrinkage and compression in the z-axis: implications for optical disector counting in vibratome-, plastic- and cryosections. J. Neurosci. Methods 124 (2003) 45-59
27. Glaser J.R., and Glaser E.M. Stereology, morphometry, and mapping: the whole is greater than the sum of its parts. J. Chem. Neuroanat. 20 (2000) 115-126
28. Gundersen H.J., Bagger P., Bendtsen T.F., Evans S.M., Korbo L., Marcussen N., Moller A., Nielsen K., Nyengaard J.R., Pakkenberg B., et al. The new stereological tools: disector, fractionator, nucleator and point sampled intercepts and their use in pathological research and diagnosis. Apmis 96 (1988) 857-881
29. Gundersen H.J., and Osterby R. Optimizing sampling efficiency of stereological studies in biology: or do more less well. J. Microsc. 121 (1981) 65-73
30. Hansen H.H., Briem T., Dzietko M., Sifringer M., Voss A., Rzeski W., Zdzisinska B., Thor F., Heumann R., Stepulak A., Bittigau P., and Ikonomidou C. Mechanisms leading to disseminated apoptosis following NMDA receptor blockade in the developing rat brain. Neurobiol. Dis. 16 (2004) 440-453
31. Hayashi M., Arai N., Satoh J., Suzuki H., Katayama K., Tamagawa K., and Morimatsu Y. Neurodegenerative mechanisms in subacute sclerosing panencephalitis. J. Child Neurol. 17 (2002) 725-730
32. Holcomb H.H., Lahti A.C., Medoff D.R., Cullen T., and Tamminga C.A. Effects of noncompetitive NMDA receptor blockade on anterior cingulate cerebral blood flow in volunteers with schizophrenia. Neuropsychopharmacology 30 (2005) 2275-2282
33. Honey G.D., Honey R.A., O'Loughlin C., Sharar S.R., Kumaran D., Suckling J., Menon D.K., Sleator C., Bullmore E.T., and Fletcher P.C. Ketamine disrupts frontal and hippocampal contribution to encoding and retrieval of episodic memory: an fMRI study. Cereb. Cortex 15 (2005) 749-759
34. Ikonomidou C., Bosch F., Miksa M., Bittigau P., Vockler J., Dikranian K., Tenkova T.I., Stefovska V., Turski L., and Olney J.W. Blockade of NMDA receptors and apoptotic neurodegeneration in the developing brain. Science 283 (1999) 70-74
35. Ishida K., Shimizu H., Hida H., Urakawa S., Ida K., and Nishino H. Argyrophilic dark neurons represent various states of neuronal damage in brain insults: some come to die and others survive. Neuroscience 125 (2004) 633-644
36. Ishimaru M.J., Ikonomidou C., Tenkova T.I., Der T.C., Dikranian K., Sesma M.A., and Olney J.W. Distinguishing excitotoxic from apoptotic neurodegeneration in the developing rat brain. J. Comp. Neurol. 408 (1999) 461-476
37. Jansen K.L. Ketamine--can chronic use impair memory?. Int. J. Addict. 25 (1990) 133-139
38. Jarrard L.E. On the role of the hippocampus in learning and memory in the rat. Behav. Neural Biol. 60 (1993) 9-26
39. Javitt D.C., and Zukin S.R. Recent advances in the phencyclidine model of schizophrenia. Am. J. Psychiat. 148 (1991) 1301-1308
40. Jevtovic-Todorovic V., and Carter L.B. The anesthetics nitrous oxide and ketamine are more neurotoxic to old than to young rat brain. Neurobiol. Aging 26 (2005) 947-956
41. Jevtovic-Todorovic V., Hartman R.E., Izumi Y., Benshoff N.D., Dikranian K., Zorumski C.F., Olney J.W., and Wozniak D.F. Early exposure to common anesthetic agents causes widespread neurodegeneration in the developing rat brain and persistent learning deficits. J. Neurosci. 23 (2003) 876-882
42. Jevtovic-Todorovic V., Wozniak D.F., Benshoff N.D., and Olney J.W. A comparative evaluation of the neurotoxic properties of ketamine and nitrous oxide. Brain Res. 895 (2001) 264-267
43. Koliatsos V.E., Dawson T.M., Kecojevic A., Zhou Y., Wang Y.F., and Huang K.X. Cortical interneurons become activated by deafferentation and instruct the apoptosis of pyramidal neurons. Proc. Natl. Acad. Sci. U.S.A. 101 (2004) 14264-14269
44. Kudoh A., Takahira Y., Katagai H., and Takazawa T. Small-dose ketamine improves the postoperative state of depressed patients. Anesth. Analg. 95 (2002) 114-118 table of contents
45. Lahti A.C., Koffel B., LaPorte D., and Tamminga C.A. Subanesthetic doses of ketamine stimulate psychosis in schizophrenia. Neuropsychopharmacology 13 (1995) 9-19
46. Lahti A.C., Weiler M.A., Tamara Michaelidis B.A., Parwani A., and Tamminga C.A. Effects of ketamine in normal and schizophrenic volunteers. Neuropsychopharmacology 25 (2001) 455-467
47. Larsen J.O., Gundersen H.J., and Nielsen J. Global spatial sampling with isotropic virtual planes: estimators of length density and total length in thick, arbitrarily orientated sections. J. Microsc. 191 (1998) 238-248
48. Malhotra A.K., Pinals D.A., Adler C.M., Elman I., Clifton A., Pickar D., and Breier A. Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics. Neuropsychopharmacology 17 (1997) 141-150
49. Maxwell C.R., Ehrlichman R.S., Liang Y., Trief D., Kanes S.J., Karp J., and Siegel S.J. Ketamine produces lasting disruptions in encoding of sensory stimuli. J. Pharmacol. Exp. Ther. 316 (2006) 315-324
50. McHugh T.J., Jones M.W., Quinn J.J., Balthasar N., Coppari R., Elmquist J.K., Lowell B.B., Fanselow M.S., Wilson M.A., and Tonegawa S. Dentate gyrus NMDA receptors mediate rapid pattern separation in the hippocampal network. Science 317 (2007) 94-99
51. McLean R.F., Baker A.J., Walker S.E., Mazer C.D., Wong B.I., and Harrington E.M. Ketamine concentrations during cardiopulmonary bypass. Can. J. Anaesth. 43 (1996) 580-584
52. Meaney M.J., Mitchell J.B., Aitken D.H., Bhatnagar S., Bodnoff S.R., Iny L.J., and Sarrieau A. The effects of neonatal handling on the development of the adrenocortical response to stress: implications for neuropathology and cognitive deficits in later life. Psychoneuroendocrinology 16 (1991) 85-103
53. Morgan C.J., Mofeez A., Brandner B., Bromley L., and Curran H.V. Acute effects of ketamine on memory systems and psychotic symptoms in healthy volunteers. Neuropsychopharmacology 29 (2004) 208-218
54. Morgan C.J.A., Rossellc S.L., Peppera F., Smartb J., Blackburnb J., Brandnerb B., and Valerie Currana H. Semantic Priming after Ketamine Acutely in Healthy Volunteers and Following Chronic Self-Administration in Substance Users. Biol. Psychiat. 59 (2005) 265-272
55. Mouton P.R., Gokhale A.M., Ward N.L., and West M.J. Stereological length estimation using spherical probes. J. Microsc. 206 (2002) 54-64
56. Nakajima W., Ishida A., Lange M.S., Gabrielson K.L., Wilson M.A., Martin L.J., Blue M.E., and Johnston M.V. Apoptosis has a prolonged role in the neurodegeneration after hypoxic ischemia in the newborn rat. J. Neurosci. 20 (2000) 7994-8004
57. Nakazawa K., McHugh T.J., Wilson M.A., and Tonegawa S. NMDA receptors, place cells and hippocampal spatial memory. Nat. Rev. Neurosci. 5 (2004) 361-372
58. Nakazawa K., Sun L.D., Quirk M.C., Rondi-Reig L., Wilson M.A., and Tonegawa S. Hippocampal CA3 NMDA receptors are crucial for memory acquisition of one-time experience. Neuron 38 (2003) 305-315
59. Newcomer J.W., Farber N.B., Jevtovic-Todorovic V., Selke G., Melson A.K., Hershey T., Craft S., and Olney J.W. Ketamine-induced NMDA receptor hypofunction as a model of memory impairment and psychosis. Neuropsychopharmacology 20 (1999) 106-118
60. Noguchi K.K., Nemmers B., and Farber N.B. Age has a similar influence on the susceptibility to NMDA antagonist-induced neurodegeneration in most brain regions. Brain Res. Dev. Brain Res. 158 (2005) 82-91
61. Olney J.W. New insights and new issues in developmental neurotoxicology. Neurotoxicology 23 (2002) 659-668
62. Olney J.W., Tenkova T., Dikranian K., Muglia L.J., Jermakowicz W.J., D'Sa C., and Roth K.A. Ethanol-induced caspase-3 activation in the in vivo developing mouse brain. Neurobiol. Dis. 9 (2002) 205-219
63. Olney J.W., Tenkova T., Dikranian K., Qin Y.Q., Labruyere J., and Ikonomidou C. Ethanol-induced apoptotic neurodegeneration in the developing C57BL/6 mouse brain. Brain Res. Dev. Brain Res. 133 (2002) 115-126
64. Olney J.W., Wozniak D.F., Farber N.B., Jevtovic-Todorovic V., Bittigau P., and Ikonomidou C. The enigma of fetal alcohol neurotoxicity. Ann. Med. 34 (2002) 109-119
65. Olney J.W., Wozniak D.F., Jevtovic-Todorovic V., Farber N.B., Bittigau P., and Ikonomidou C. Drug-induced apoptotic neurodegeneration in the developing brain. Brain Pathol. 12 (2002) 488-498
66. Olney J.W., Wozniak D.F., Jevtovic-Todorovic V., Farber N.B., Bittigau P., and Ikonomidou C. Glutamate and GABA receptor dysfunction in the fetal alcohol syndrome. Neurotox. Res. 4 (2002) 315-325
67. Ostroff R., Gonzales M., and Sanacora G. Antidepressant effect of ketamine during ECT. Am. J. Psychiat. 162 (2005) 1385-1386
68. Paxinos G., and Franklin K. The Mouse Brain in Stereotaxic Coordinates (1997), Academic Press, San Diego
69. Rajgopal Y., and Vemuri M.C. Calpain activation and alpha-spectrin cleavage in rat brain by ethanol. Neurosci. Lett. 321 (2002) 187-191
70. Rajji T., Chapman D., Eichenbaum H., and Greene R. The role of CA3 hippocampal NMDA receptors in paired associate learning. J. Neurosci. 26 (2006) 908-915
71. Richebe P., Rivat C., Laulin J.P., Maurette P., and Simonnet G. Ketamine improves the management of exaggerated postoperative pain observed in perioperative fentanyl-treated rats. Anesthesiology 102 (2005) 421-428
72. Rothstein R.P., and Levison S.W. Gray matter oligodendrocyte progenitors and neurons die caspase-3 mediated deaths subsequent to mild perinatal hypoxic/ischemic insults. Dev. Neurosci. 27 (2005) 149-159
73. Rowland L.M., Astur R.S., Jung R.E., Bustillo J.R., Lauriello J., and Yeo R.A. Selective cognitive impairments associated with NMDA receptor blockade in humans. Neuropsychopharmacology 30 (2005) 633-639
74. Rudin M., Ben-Abraham R., Gazit V., Tendler Y., Tashlykov V., and Katz Y. Single-dose ketamine administration induces apoptosis in neonatal mouse brain. J. Basic Clin. Physiol. Pharmacol. 16 (2005) 231-243
75. Sapolsky R.M., Uno H., Rebert C.S., and Finch C.E. Hippocampal damage associated with prolonged glucocorticoid exposure in primates. J. Neurosci. 10 (1990) 2897-2902
76. Siegel S.J., Brose N., Janssen W.G., Gasic G.P., Jahn R., Heinemann S.F., and Morrison J.H. Regional, cellular, and ultrastructural distribution of N-methyl-d-aspartate receptor subunit 1 in monkey hippocampus. Proc. Natl. Acad. Sci. U.S.A. 91 (1994) 564-568
77. Siegel S.J., Ginsberg S.D., Hof P.R., Foote S.L., Young W.G., Kraemer G.W., McKinney W.T., and Morrison J.H. Effects of social deprivation in prepubescent rhesus monkeys: immunohistochemical analysis of the neurofilament protein triplet in the hippocampal formation. Brain Res. 619 (1993) 299-305
78. Simonati A., Filosto M., Savio C., Tomelleri G., Tonin P., Dalla Bernardina B., and Rizzuto N. Features of cell death in brain and liver, the target tissues of progressive neuronal degeneration of childhood with liver disease (Alpers-Huttenlocher disease). Acta. Neuropathol. (Berl.) 106 (2003) 57-65
79. Slikker W., Xu Z., and Wang C. Application of a systems biology approach to developmental neurotoxicology. Reprod. Toxicol. 19 (2005) 305-319
80. Stein-Behrens B., Mattson M.P., Chang I., Yeh M., and Sapolsky R. Stress exacerbates neuron loss and cytoskeletal pathology in the hippocampus. J. Neurosci. 14 (1994) 5373-5380
81. Stiedl O., Birkenfeld K., Palve M., and Spiess J. Impairment of conditioned contextual fear of C57BL/6J mice by intracerebral injections of the NMDA receptor antagonist APV. Behav. Brain Res. 116 (2000) 157-168
82. Sultana R., and Babu P.P. Ethanol-induced alteration in N-methyl-d-aspartate receptor 2A C-terminus and protein kinase C activity in rat brain. Neurosci. Lett. 349 (2003) 45-48
83. Tashlykov V., Katz Y., Gazit V., Zohar O., Schreiber S., and Pick C.G. Apoptotic changes in the cortex and hippocampus following minimal brain trauma in mice. Brain Res. 1130 (2007) 197-205
84. Umbricht D., Schmid L., Koller R., Vollenweider F., Hell D., and Javitt D. Ketamine-induced deficits in auditory and visual context-dependent processing in healthy volunteers: implications for models of cognitive deficits in schizophrenia. Arch. Gen. Psychiat. (2000) 57
85. Vollenweider F.X., Leenders K.L., Scharfetter C., Antonini A., Maguire P., Missimer J., and Angst J. Metabolic hyperfrontality and psychopathology in the ketamine model of psychosis using positron emission tomography (PET) and (18F)fluorodeoxyglucose (FDG). Eur. Neuropsychopharmacol. 7 (1997) 9-24
86. Wang C.Z., and Johnson K.M. The Role of caspase-3 activation in phencyclidine induced neuronal death in postnatal rats. Neuropsychopharmacology 32 (2007) 1178-1194
87. West M.J. New stereological methods for counting neurons. Neurobiol. Aging 14 (1993) 275-285
88. West M.J. Stereological methods for estimating the total number of neurons and synapses: issues of precision and bias. Trends Neurosci. 22 (1999) 51-61
89. Wozniak D.F., Brosnan-Watters G., Nardi A., McEwen M., Corso T.D., Olney J.W., and Fix A.S. MK-801 neurotoxicity in male mice: histologic effects and chronic impairment in spatial learning. Brain Res. 707 (1996) 165-179
90. Wozniak D.F., Dikranian K., Ishimaru M.J., Nardi A., Corso T.D., Tenkova T., Olney J.W., and Fix A.S. Disseminated corticolimbic neuronal degeneration induced in rat brain by MK-801: potential relevance to Alzheimer's disease. Neurobiol. Dis. 5 (1998) 305-322
91. Wu L., Schlenger W., and Galvin D. Concurrent use of methamphetamine, MDMA, LSD, ketamine, GHB, and flunitrazepam among American youths. Drug Alcohol Depend. 84 (2006) 102-113
92. Young C., Jevtovic-Todorovic V., Qin Y.Q., Tenkova T., Wang H., Labruyere J., and Olney J.W. Potential of ketamine and midazolam, individually or in combination, to induce apoptotic neurodegeneration in the infant mouse brain. Br. J. Pharmacol. 146 (2005) 189-197
93. Young S.L., Bohenek D.L., and Fanselow M.S. NMDA processes mediate anterograde amnesia of contextual fear conditioning induced by hippocampal damage: immunization against amnesia by context preexposure. Behav. Neurosci. 108 (1994) 19-29
94. Zarate Jr. C.A., Singh J.B., Carlson P.J., Brutsche N.E., Ameli R., Luckenbaugh D.A., Charney D.S., and Manji H.K. A randomized trial of an N-methyl-d-aspartate antagonist in treatment-resistant major depression. Arch. Gen. Psychiat. 63 (2006) 856-864
95. Zsombok A., Toth Z., and Gallyas F. Basophilia, acidophilia and argyrophilia of "dark" (compacted) neurons during their formation, recovery or death in an otherwise undamaged environment. J. Neurosci. Methods 142 (2005) 145-152